Immunotherapy for advanced and recurrent malignant pleural mesothelioma

Anna Karen Haugaard; Rita Saude Conde; Ana Rita J Maria; Abhijna Vithal Yergolkar; Karsten Juhl Jørgensen; Bruno Heleno

doi:10.1002/14651858.CD014720

Immunotherapy for advanced and recurrent malignant pleural mesothelioma

Anna Karen Haugaard^*, Rita Saude Conde, Ana Rita J Maria, Abhijna Vithal Yergolkar, Karsten Juhl Jørgensen, Bruno Heleno

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors (single-agent or combination therapy) in people with advanced malignant pleural mesothelioma in a first-line or salvage setting.

Original language	English
Article number	CD014720
Journal	Cochrane Database of Systematic Reviews
Volume	2024
Issue number	9
ISSN	1465-1858
DOIs	https://doi.org/10.1002/14651858.CD014720
Publication status	Published - 18. Sept 2024

Keywords

Humans
Immune Checkpoint Inhibitors/therapeutic use
Immunotherapy/methods
Lung Neoplasms/therapy
Mesothelioma, Malignant/therapy
Mesothelioma/therapy
Neoplasm Recurrence, Local
Pleural Neoplasms/therapy
Randomized Controlled Trials as Topic
Salvage Therapy/methods

Documents & Links

10.1002/14651858.CD014720

https://pmc.ncbi.nlm.nih.gov/articles/PMC11409431/pdf/CD014720.pdf

SDU Link

Check access to the material in SDU Library's search engine

Cite this

@article{e3b0a07a8a6542449f50a36b65a880f0,

title = "Immunotherapy for advanced and recurrent malignant pleural mesothelioma",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors (single-agent or combination therapy) in people with advanced malignant pleural mesothelioma in a first-line or salvage setting.",

keywords = "Humans, Immune Checkpoint Inhibitors/therapeutic use, Immunotherapy/methods, Lung Neoplasms/therapy, Mesothelioma, Malignant/therapy, Mesothelioma/therapy, Neoplasm Recurrence, Local, Pleural Neoplasms/therapy, Randomized Controlled Trials as Topic, Salvage Therapy/methods",

author = "Haugaard, {Anna Karen} and {Saude Conde}, Rita and {J Maria}, {Ana Rita} and {Vithal Yergolkar}, Abhijna and J{\o}rgensen, {Karsten Juhl} and Bruno Heleno",

year = "2024",

month = sep,

day = "18",

doi = "10.1002/14651858.CD014720",

language = "English",

volume = "2024",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "Wiley",

number = "9",

}

TY - JOUR

T1 - Immunotherapy for advanced and recurrent malignant pleural mesothelioma

AU - Haugaard, Anna Karen

AU - Saude Conde, Rita

AU - J Maria, Ana Rita

AU - Vithal Yergolkar, Abhijna

AU - Jørgensen, Karsten Juhl

AU - Heleno, Bruno

PY - 2024/9/18

Y1 - 2024/9/18

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors (single-agent or combination therapy) in people with advanced malignant pleural mesothelioma in a first-line or salvage setting.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors (single-agent or combination therapy) in people with advanced malignant pleural mesothelioma in a first-line or salvage setting.

KW - Humans

KW - Immune Checkpoint Inhibitors/therapeutic use

KW - Immunotherapy/methods

KW - Lung Neoplasms/therapy

KW - Mesothelioma, Malignant/therapy

KW - Mesothelioma/therapy

KW - Neoplasm Recurrence, Local

KW - Pleural Neoplasms/therapy

KW - Randomized Controlled Trials as Topic

KW - Salvage Therapy/methods

U2 - 10.1002/14651858.CD014720

DO - 10.1002/14651858.CD014720

M3 - Journal article

C2 - 39291744

AN - SCOPUS:85204475296

SN - 1465-1858

VL - 2024

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 9

M1 - CD014720

ER -

Immunotherapy for advanced and recurrent malignant pleural mesothelioma

Abstract

Keywords

Documents & Links

SDU Link

Fingerprint

Cite this